NMI: a potential biomarker for tumor prognosis and immunotherapy

N-Myc and STAT Interactor protein (NMI) is an interferon inducible protein participating in various cellular activities, and is widely involved in the process of tumorigenesis and progression. Studies have shown that the loss of NMI expression in breast cancer can promote its progression by inducing...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Teng He, Yinbiao Qiao, Qi Yang, Jie Chen, Yongyuan Chen, Xiaoke Chen, Zhixing Hao, Mingjie Lin, Zheyu Shao, Pin Wu, Feng Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	NMI pan-cancer prognostic biomarker immune infiltration bioinformatics
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1047463/full